Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 6/2012

01.06.2012 | Gynecologic Oncology

Clinicopathological features and immunoprofile of 30 cases of Brenner ovarian tumors

verfasst von: A. Kondi-Pafiti, Evi Kairi-Vassilatou, Ch. Iavazzo, Em. Vouza, P. Mavrigiannaki, Ch. Kleanthis, D. Vlahodimitropoulos, A. Liapis

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

Aim

The aim of this study was to investigate the clinicopathological and immunopathological features of Brenner ovarian tumors.

Materials and methods

Thirty cases of Brenner ovarian tumors were examined in our laboratory among 1,680 cases of ovarian tumors, representing 1.5% of all tumors examined. Blocks of paraffin-embedded tumor tissue for all cases were available for additional immunohistochemical stain by a Ventana autoimmunostainer. Moreover, antibodies for Uroplakine III (cellmarque AU-1 clone, 1:25) Chromogen (monosan clone 5H7,1:25) WT1 (novocastra, clone 3F-H2, 1:25) NSE (DAKO, clone BB5/NC/V1-H14, 1:50), CK20 (DAKO, clone Ks20.8, 1:50),CK7 (Zymed 1:25, clone V-TL12/30)were used.

Results

The mean age of the patients was 51.4 years ranging from 16 to 82 years. The tumor was unilateral in 28 cases (16/28 in the right ovary and 12/28 in the left ovary) and bilateral in two cases. Twenty-eight cases (93%) were benign and two (7%) were proliferating (borderline) tumors. Seventeen cases (56%) were pure Brenner tumors, measuring from 0.5 to 2.5 cm and 13 cases (44%) were mixed tumors consisting of a Brenner tumor element and a mucinous ovarian tumor (10/13 cases, 53.8%) and a germ cell tumor in 3/13 cases. The largest diameter of the mixed tumors ranged from 7 to 22 cm. The largest area consisting of Brenner elements measured 7 cm. The immunoprofile of Brenner tumor cell was cytokeratine-7 positive (30/30 cases) cytokeratine-20 negative in the Brenner cell element but positive in the mucinous component in 5/7 cases of mixed Brenner tumors, focally WT-1 positive (5/30 cases), NSE negative (0/30 cases) and focally chromogranine positive (6/30 cases), Uroplakin-III positive in 23/30 cases, with faint cytoplasmatic or luminal distribution. In conclusion, Brenner ovarian tumors are unilateral, small and benign neoplasms in their majority and present specific histopathological and immunopathological characteristics and mixed forms with other epithelial and germ cell neoplasms. This could be explained as a form of metaplasia or a diverse histogenesis from surface epithelium and/or the germ cell ovarian component.
Literatur
1.
Zurück zum Zitat Brenner F (1907) Das Oophoroma folliculare. Frankfurt Z Pathol 1:150–171 Brenner F (1907) Das Oophoroma folliculare. Frankfurt Z Pathol 1:150–171
2.
Zurück zum Zitat Waxman M (1979) Pure and mixed Brenner tumors of the ovary: clinicopathologic and histogenetic observations. Cancer 43(5):1830–1839PubMedCrossRef Waxman M (1979) Pure and mixed Brenner tumors of the ovary: clinicopathologic and histogenetic observations. Cancer 43(5):1830–1839PubMedCrossRef
3.
Zurück zum Zitat Scully RE (1999) Histological Typing of Ovarian Tumors: World Health Organization International Histological Classification of Tumors. Springer-Verlag, Berlin Scully RE (1999) Histological Typing of Ovarian Tumors: World Health Organization International Histological Classification of Tumors. Springer-Verlag, Berlin
4.
Zurück zum Zitat Scully RE, Young RH, Clement PB (1998) Tumors of the ovary, Maldeveloped Gonads, Fallopian Tube and Broad Ligaments. Armed Forces Institute of Pathology, Washington, pp 153–163 Scully RE, Young RH, Clement PB (1998) Tumors of the ovary, Maldeveloped Gonads, Fallopian Tube and Broad Ligaments. Armed Forces Institute of Pathology, Washington, pp 153–163
5.
Zurück zum Zitat Shevchuk MM, Fenoglio CM, Richart RM (1980) Histogenesis of Brenner tumors, II: histochemistry and CEA. Cancer 46(12):2617–2622PubMedCrossRef Shevchuk MM, Fenoglio CM, Richart RM (1980) Histogenesis of Brenner tumors, II: histochemistry and CEA. Cancer 46(12):2617–2622PubMedCrossRef
6.
Zurück zum Zitat Riedel I, Czernobilsky B, Lifschitz-Mercer B, Roth LM, Wu XR, Sun TT, Moll R (2001) Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins. Virchows Arch 438(2):181–191PubMedCrossRef Riedel I, Czernobilsky B, Lifschitz-Mercer B, Roth LM, Wu XR, Sun TT, Moll R (2001) Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins. Virchows Arch 438(2):181–191PubMedCrossRef
7.
Zurück zum Zitat Santini D, Gelli MC, Mazzoleni G, Ricci M, Severi B, Pasquinelli G, Pelusi G, Martinelli G (1989) Brenner tumor of the ovary: a correlative histologic, histochemical, unohistochemical, and ultrastructural investigation. Hum Pathol 20(8):787–795PubMedCrossRef Santini D, Gelli MC, Mazzoleni G, Ricci M, Severi B, Pasquinelli G, Pelusi G, Martinelli G (1989) Brenner tumor of the ovary: a correlative histologic, histochemical, unohistochemical, and ultrastructural investigation. Hum Pathol 20(8):787–795PubMedCrossRef
8.
Zurück zum Zitat Nomura K, Aizawa S (1997) A histogenetic consideration of ovarian mucinous tumors based on an analysis of lesions associated with teratomas or Brenner tumors. Pathol Intern 47(12):862–865CrossRef Nomura K, Aizawa S (1997) A histogenetic consideration of ovarian mucinous tumors based on an analysis of lesions associated with teratomas or Brenner tumors. Pathol Intern 47(12):862–865CrossRef
9.
Zurück zum Zitat Ogawa K, Johansson SL, Cohen SM (1999) Immunohistochemical analysis of uroplakins, urothelial specific proteins, in ovarian Brenner tumors, normal tissues, and benign and neoplastic lesions of the female genital tract. Am J Pathol 155(4):1047–1050PubMedCrossRef Ogawa K, Johansson SL, Cohen SM (1999) Immunohistochemical analysis of uroplakins, urothelial specific proteins, in ovarian Brenner tumors, normal tissues, and benign and neoplastic lesions of the female genital tract. Am J Pathol 155(4):1047–1050PubMedCrossRef
10.
Zurück zum Zitat Ordóñez NG, Mackay B (2000) Brenner tumor of the ovary: a comparative immunohistochemical and ultrastructural study with transitional cell carcinoma of the bladder. Ultrastruct Pathol 24(3):157–167PubMedCrossRef Ordóñez NG, Mackay B (2000) Brenner tumor of the ovary: a comparative immunohistochemical and ultrastructural study with transitional cell carcinoma of the bladder. Ultrastruct Pathol 24(3):157–167PubMedCrossRef
11.
Zurück zum Zitat Parker DC, Folpe AL, Bell J, Oliva E, Young RH, Cohen C, Amin MB (2003) Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas. Am J Surg Pathol 27(1):1–10PubMedCrossRef Parker DC, Folpe AL, Bell J, Oliva E, Young RH, Cohen C, Amin MB (2003) Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas. Am J Surg Pathol 27(1):1–10PubMedCrossRef
Metadaten
Titel
Clinicopathological features and immunoprofile of 30 cases of Brenner ovarian tumors
verfasst von
A. Kondi-Pafiti
Evi Kairi-Vassilatou
Ch. Iavazzo
Em. Vouza
P. Mavrigiannaki
Ch. Kleanthis
D. Vlahodimitropoulos
A. Liapis
Publikationsdatum
01.06.2012
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 6/2012
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-011-2182-5

Weitere Artikel der Ausgabe 6/2012

Archives of Gynecology and Obstetrics 6/2012 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.